Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA07 - Overcoming Resistance to EGFR Inhibitors
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Dana Lucia Stanculeanu, Ross Soo
-
+
Session Moderator
13:07 - 13:15 | Presenter: Dana Lucia Stanculeanu
- Abstract
Loading... -
+
Session Moderator
13:07 - 13:15 | Presenter: Ross Soo
- Abstract
Loading... -
+
MA07.01 - Session Introduction
12:15 - 12:16 | Presenter: Dana Lucia Stanculeanu
- Abstract
Loading... -
+
MA07.02 - Session Introduction
12:16 - 12:17 | Presenter: Ross Soo
- Abstract
Loading... -
+
MA07.03 - Real-world Landscape of EGFR C797X Mutation as a Resistance Mechanism to Osimertinib in Non-small Cell Lung Cancer
12:17 - 12:22 | Presenter: Suresh S. Ramalingam | Author(s): Nicole Zhang, Junhua Yu, Carin Espenschied, Teresa Green, Joshua Infantine, Brenton G Mar
- Abstract
Loading... -
+
MA07.04 - Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
12:22 - 12:27 | Presenter: Melina Elpi Marmarelis | Author(s): Se-Hoon Lee, Alexander I. Spira, Sai-Hong Ignatius Ou, Saiama Waqar, Shengting Li, Meena Thayu, Roland E Knoblauch, Joshua M Bauml, Byoung Chul Cho
- Abstract
Loading... -
+
MA07.05 - Phase 1b/2 Study of Combined HER Inhibition in Refractory EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
12:27 - 12:32 | Presenter: Jonathan Goldman | Author(s): Holly K.T. Huang, Amy Lauren Cummings, Zorawar Noor, Samuel Slomowitz, Evangelia Kirimis, Olga Olevsky, Karo Arzoo, Shahryar Ashouri, Brian DiCarlo, Eddie Hong-Lung Hu, Deborah J. Wong, James Chauv, Edward B. Garon, Yosef Yarden, Dennis Slamon
- Abstract
Loading... -
+
MA07.06 - Discussant
12:32 - 12:42 | Presenter: Laura Mezquita
- Abstract
Loading... -
+
MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA
12:42 - 12:47 | Presenter: Laura Mezquita | Author(s): Leslie Bucheit, Juan Carlos Laguna, Belén Pastor, Cristina Teixido, Teresa Gorria, Victor Albarrán, Marta Garcia de Herreros, Roxana Reyes, Noemi Reguart, Nuria Viñolas, Ainara Arcocha, Joan Anton Puig-Butillé, Leylah Drusbosky, Iris Faull, Edouard Auclin, Elena Castro, Jyoti Patel, Aleix Prat, Benjamin Besse
- Abstract
Loading... -
+
MA07.08 - JIN-A02, a Highly Effective 4th Generation EGFR-TKI, Targeting EGFR C797S Triple Mutation in NSCLC
12:47 - 12:52 | Presenter: Byoung Chul Cho | Author(s): Mi Ran Yun, Mi Ra Yu, Krishna Babu Duggirala, Kwangho Lee, Anna Jo, Ethan Seah, Choonok Kim
- Abstract
Loading... -
+
MA07.09 - BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study
12:52 - 12:57 | Presenter: Sun Min Lim | Author(s): Jin Seok Ahn, Min-Hee Hong, Tae Min Kim, Hyun-Ae Jung, Sai-Hong Ignatius Ou, Sungchan Jeong, Yong-Hee Lee, Eunsil Yim, Sujin Jung, Sang-Yoon Lee, Dong-Wan Kim
- Abstract
Loading... -
+
MA07.10 - Discussant
12:57 - 13:07 | Presenter: Pasi A Janne
- Abstract
Loading... -
+
MA07.11 - Live Q&A
13:07 - 13:15
- Abstract
Loading...
